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New Roles for Classical Immune Proteins
Traditionally, the functions of classical immune molecules were thought to be restricted to the immune system. However,
accumulating evidence demonstrates that some immune proteins contribute to neuronal function. Building upon these obser-
vations, McConnell et al. provide direct evidence for a role of MHCI molecules in cerebellar synaptic plasticity and behavior.
The authors found that the classicalMHCImolecules H2-Kb andH2-Db are selectively expressed in Purkinje cells and that loss
of these proteins led to a lower LTD induction threshold at cerebellar synapses and enhancedmotor learning in mice. A recent
study by Atwal et al. further expands the role of immune molecules in the nervous system to include the modulation of axonal
growth and the regulation of axon regeneration. Three myelin proteins (Nogo, MAG, and OMgP) inhibit axon regeneration.
Deletion of their receptor NgR does not fully prevent their inhibitory effects, suggesting that another receptor may be involved.
In search of this receptor, the authors discovered that PirB, anMHCI receptor previously implicated in synaptic plasticity, acts
as a high-affinity receptor for Nogo,MAG, andOMgP. Blocking both PirB andNgR prevented nearly all of the inhibitory effects
of these proteins on axon outgrowth, raising the exciting possibility that targeting the activity of both NgR and PirB in vivo
might potentially stimulate axon regeneration.
McConnell et al. (2009). PNAS 106, 6784–6789.
Atwal et al. (2008). Science 322, 967–970.
T Cells on the Move in the Brain
T lymphocyte entry into the central nervous system is rare except in cases of infection
or autoimmunity. In other tissues, pre-existing cellular scaffolds are known to guide
lymphocyte migration, but there is no evidence that such structures exist in the brain.
To gain insight into the behavior of T lymphocytes in the brain, Wilson et al. monitored
the cellular dynamics of CD8+ T lymphocytes in mice with toxoplasmic encephalitis,
a model of infection-induced CNS inflammation. They discovered two distinct T cell
populations: one with relatively constrained migration and one with surprisingly
dynamic behavior. Movement of the dynamic T cells was linked to formation of a
network of reticular structures that were induced in the brain in areas of inflammation
and parasite replication to guide lymphocyte migration. Although a complete under-
standing of the source and composition of these networks awaits future work, target-
ing these structures may be an effective means of regulating T cell-mediated inflam-
mation in the CNS.
Wilson et al. (2009). Immunity 30, 300–311.
Immune Link to Schizophrenia
It is thought that the immune system may play a role in psychiatric diseases such as
depression and schizophrenia. Three recent genome-wide association studies of
schizophrenia highlight chromosomal regions of interest linked to the disease, including a region on chromosome 6 that
contains a number of major histocompatibility complex genes. These findings confirm earlier linkage studies suggesting
an involvement of this region in the disease and are consistent with the notion that immune proteins may contribute to schizo-
phrenia. Given the presence of other nonimmune genes in this region, however, further research is required to confirm a role
for MHC molecules in the disease.
Stefansson et al. (2009). Nature 460, 744–747.
The International Schizophrenia Consortium (2009). Nature 460, 748–752.
Shi et al. (2009). Nature 460, 753–757.
Crossing the Blood-Brain Barrier
The cells of the blood-brain barrier (BBB) form tight intercellular junctions that form a barrier between the body and the brain to
prevent access of would-be invaders to the CNS. However, as with all defenses, the BBB has weaknesses and breaches do
occur. The question is: how? Two recent studies offer new insights into themechanisms of invasion through the BBB. Coureuil
et al. found that Neisseria meningitidis, a pathogen responsible for cerebrospinal meningitis, gains entry to the CNS by
adhering to brain endothelial cells and hijacking the intrinsic Par3/Par6/PKCz polarity complex. Binding of the bacteria re-
cruited the complex to form ectopic junction-like domains, leading to sequestration of the polarity proteins and, ultimately,
destabilization of the BBB junctions. In a separate study, Buonamici et al. investigated the mechanism underlying T cell infil-
tration during acute lymphoblastic leukemia (T-ALL) following activation of Notch1 signaling, known to be altered in most
T-ALL patients. They identified the chemokine receptor CCR7 as an adhesion regulator upregulated by Notch1, and its inter-
action with the CCL19 ligand was essential for recruitment of leukemia cells to the CNS.
Coureuil et al. (2009). Science 325, 83–87.
Buonamici et al. (2009). Nature 459, 1000–1004.
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Inflammation Mediates Dopaminergic Neuron Death
Previous research suggests that inflammation contributes to a number of neurodegen-
erative diseases, includingParkinson’s disease.Nurr1, an orphannuclear receptor that
acts as a constitutively active transcription factor, is known to play a role in the gener-
ation and maintenance of dopaminergic neurons, and mutations in this protein have
been linked to a familial formof Parkinson’s disease. In a recent study, Saijo et al. found
that Nurr1 protects dopaminergic neurons from inflammation-induced neurotoxicity by
repressing the expression of inflammatory mediators that trigger cell death. Nurr1
recruitment of the CoREST corepressor complex resulted in transcriptional repression
of proinflammatory target genes in microglia and astrocytes. Reduction of Nurr1 led to
exaggerated inflammatory responses and dopaminergic neuronal death, supporting
the concept that suppression of inflammatory signaling in the brain could be a useful
therapeutic approach for treatment of Parkinson’s disease.
Saijo et al. (2009). Cell 137, 47–59.
Immune System Contribution to Epilepsy
While the molecular mechanisms that contribute to the development of epilepsy are
not fully understood, inflammation may play a role, in part by stimulating the break-
down of the blood-brain barrier (BBB). Two recent studies by Fabene et al. and Kim
et al. build upon this idea. Kim et al. visualized the activity of CD8+ T cells during
lymphocytic choriomeningitis virus infection, finding that T cell activation leads to
the release of chemokines that subsequently trigger influx of neutrophils and mono-
cytes into the brain, breakdown of the BBB, and development of seizures. In
a complementary study, Fabene et al. found that seizures induced elevated expression of vascular cell adhesion molecules
that promote interaction between leukocytes and vascular cells. Blocking leukocyte-vascular interactions prevented BBB
leakage and reduced seizures. Together, these findings demonstrate a link between leukocyte-vascular interactions, BBB
leakage, and seizure generation. Given the uncertainty regarding the relevance of mouse models to human epilepsy and
the potential complications of interfering with immune function, it remains to be seen whether preventing breakdown of
the BBB might be a viable therapeutic approach for seizures.
Kim et al. (2009). Nature 457, 191–197.
Fabene et al. (2009). Nature Medicine 14, 1377–1383.
Two Waves of Lymphocyte Invasion in Autoimmune Disease
Interleukin 17-producing T cells (TH-17 cells) are involved in the onset and mainte-
nance of experimental autoimmune encephalitis (EAE), a mouse model of multiple
sclerosis. How and where these T cells gain entry to the CNS to initiate inflammation
remains unclear. Recently, Reboldi et al. found evidence for two distinct waves of
T cell migration into the CNS during EAE, with distinct molecular requirements and
sites of lymphocyte entry. In mice lacking the chemokine receptor CCR6, TH-17 cells
did not migrate into the CNS, and the mice were resistant to developing EAE.
Signaling via CCR6, its ligand CCL20 appeared to control the initial infiltration of
autoreactive TH-17 cells into the uninflamed CNS at the choroid plexus. This initial
migration of TH-17 cells triggered activation of parenchymal endothelial cells, leading
to recruitment of a second wave of TH-17 and TH1 cells that gain entry to the CNS via
the BBB in a CCR6-independent manner. This two-wave mode of migration may also
be relevant to the development and progression of other autoimmune diseases.
Reboldi et al. (2009). Nature Immunology 10, 514–523.
Multiple Antigen Recognition in MS
The pathogenic changes underlying autoimmune disorders are thought to be initiated
and driven by T cell populations that recognize and respond to autoantigens. In
a recent study aimed at exploring the role of the autoantigen in spontaneous autoim-
munity, Krishnamoorthy et al. studied a transgenic mouse expressing a myelin oligodendrocyte glycoprotein (MOG)-specific
T cell receptor. As predicted, the mice developed spontaneous experimental autoimmune encephalitis (EAE), a mouse model
of multiple sclerosis, in the presence of MOG. Unexpectedly, the mice also developed EAE in the absence of MOG due to
recognition of a non-MOG autoantigen corresponding to an epitope on neurofilament NF-M. The authors refer to the recog-
nition of multiple independent autoantigens by a single T cell population as cumulative autoimmunity and suggest that these
additive responses contribute to particularly vigorous immune reactions and may play a role in spontaneously developing
autoimmune disorders in humans.
Krishnamoorthy et al. (2009). Nature Medicine 15, 626–632.
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Maternal Influences on Cognitive Development
During pregnancy, the close interaction between mother and fetus means that maternal exposure to environmental toxins or
infections and maternal reactions to these exposures may also be transmitted to the fetus, potentially leading to develop-
mental defects. Such concerns are highlighted by studies linking maternal infection to schizophrenia and autism. In a recent
study, Lee et al. examined fetal brain development and cognition in offspring from a maternal systemic lupus erythematosus
(SLE) mouse model. Lupus is a chronic autoimmune disorder in which a large proportion of sufferers possess autoantibodies
capable of binding DNA and, surprisingly, similar molecular motifs within NMDA receptors. The authors found that these
maternal NMDAR-specific autoantibodies reached the developing neocortex of the fetus, inducing neuronal cell death,
large-scale disorganization of neocortical structure, and cognitive impairment. While these data suggest an intriguing mech-
anismbywhich thematernal immune system could impact cognitive development, it remains to be shownwhere the attack on
NMDARs might occur and what cellular mechanisms are involved.
Lee et al. (2009). Nature Medicine 15, 91–96.
Amyloid-b Clearance by the Immune System
Extracellular amyloid-b (Ab) plaques are a cardinal symptom of Alzheimer’s disease
(AD), and enhancing Ab clearance has been explored as a potential therapy. One
promising avenue aims to harness the body’s own immune system, and recent
work from Zhao et al. supports this approach by demonstrating that macrophages
can effectively degrade both soluble and insoluble Ab in an ex vivo brain preparation.
Efficacy of degradation depended on the particular isoform of ApoE expressed, with
the E4 variant, which has been linked to AD, being the least efficient and the E2
variant, which reduces AD risk, being the most efficient. Interestingly, macrophage
secretion of the MMP-9 extracellular protease known to degrade Ab was also corre-
lated with ApoE type, suggesting a possible cellular substrate for genetically deter-
mined AD risk factors. In a separate study, Britschgi et al. find that intrinsic antibodies
against Ab derived from either AD patients or healthy subjects can confer protection
on cultured neurons exposed to toxic Ab. The antibodies are most reactive to oligo-
meric and posttranslationally modified toxic forms of Ab and, surprisingly, to other
peptides associated with autosomal dementia (mutant Ab, Abri, and ADan). Interest-
ingly, titers of these antibodies decreased with age and disease progression,
perhaps highlighting a point of increased susceptibility in the elderly.
Zhao et al. (2009). J. Neurosci. 29, 3603–3612.
Britschgi et al. (2009). PNAS 106, 12145–12150.
The Two Faces of Macrophages in Spinal Cord Injury
Following the initial insult of spinal cord injury, activated resident microglia and infiltrating macrophages stage an inflamma-
tory response with reported effects that are paradoxically both regenerative and detrimental. Two recent studies investigated
different aspects of this contradiction. Gensel et al. reported that microinjection of
zymosan (a robust activator of macrophages) into the spinal cord generates a neuro-
trophic gradient that promotes axonal growth toward the injection site through an
apparent ‘‘tunnel’’ of reactive microglia embedded in the region of inflammation.
Increasing proximity to the zymosan focus, however, results in abortive growth,
phagocytic uptake of degenerated axonal remnants, and cell death, events likely
dependent upon infiltratingmacrophages, as selective depletion of circulatingmono-
cytes reduced zymosan-associated pathology. Although the resident microglia and
infiltrating macrophage populations have been considered functionally identical–that
is proinflammatory and destructive–Shechter et al. recently suggested they could
have distinct functions after spinal cord injury depending on their origin. By specifi-
cally labeling and manipulating the monocyte-derived macrophage population, the
authors found that augmentation of this population enhanced motor recovery while
elimination resulted in increased lesion size. Interestingly, these infiltrating macro-
phages seem to regulate activation of the proinflammatory resident microglia
through signaling by the anti-inflammatory cytokine IL-10. While these studies repre-
sent differing experimental paradigms, they underscore the functional heterogeneity
and potential benefits of macrophages and highlight the challenges to dissecting the
immune response following spinal cord injury.
Gensel et al. (2009). J. Neurosci. 29, 3956–3968.
Schechter et al. (2009). PLoS Medicine 6, e1000113.
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Cytokine Signaling and Neuropathic Pain
After nerve damage or other such insults, chronic sensations of pain and pain-hypersensitivity to normally innocuous stimuli
often ensue. While the exact origin of this neuropathic pain is uncertain, nd perhaps there is no single cause, the general
consensus is that interactions between neurons and the resident microglia of the nervous system play a pivotal role, in
part through cytokine signaling. Tsuda et al. recently found that microglial activation and subsequent neuropathic pain
following nerve injury was due to stimulation of cytokine IFN-g receptors on microglia. The Lyn tyrosine kinase and the
P2X4 receptor appeared to act as downstream mediators in the response. Signaling through the chemokine receptor
CCR2 and its ligand, CCL2, has also been implicated in neuropathic pain, and in a separate study, Jung et al. discovered
that in a demyelination model of neuropathic pain, receptor activation occurs primarily in the periphery, including at the injury
site and the DRG, explaining the rapid action of peripherally administered CCR2 antagonists. These studies add to the
evidence implicating cytokine signaling in neuropathic pain and expand our toehold for therapeutic intervention.
Tsuda et al. (2009). PNAS 106, 8032–8037.
Jung et al. (2009). J. Neurosci. 29, 8051–8062.
The Immunological Synapse Links to Narcolepsy
Hallmarks of narcolepsy include sleep/wake dysfunction and cataplexy, a sudden loss of muscle tone, which have been
linked to loss of hypocretin-secreting, hypothalamic neurons that regulate wakefulness. How these neurons are lost remains
an open question, although increasing evidence supports an autoimmune etiology in some cases due to a close genetic asso-
ciation between the disorder and the HLA locus, a key component of the immunological synapse. Susceptibility factors
beyond the HLA genotype are also thought to play a role, and Hallmayer et al. recently identified a familiar partner. In
a genome-wide association study of hundreds of subjects across three ethnic populations, they uncovered evidence that vari-
ations in the TRA@-locus are linked to the disorder. As the TRA@-locus codes for the a subunit in a T cell receptor, the HLA
partner at the immunological synapse, the study provides further support for an autoimmune origin of narcolepsy.
Hallmayer et al. (2009). Nature Genetics 41, 708–711.
Brain-Specific IL-1 Signaling
Interleukin-1 (IL-1) has a number of physiological roles, and in the CNS, IL-1 signaling
can exacerbate neurodegeneration in response to traumatic brain injury, seizure, or
acute ischemic insult. The specific mechanisms by which IL-1 acts in the nervous
system are not fully understood. By identifying an isoform of the IL-1 receptor acces-
sory protein (termed AcPb) that is expressed exclusively in the CNS, Smith et al.
recently provided evidence for a neuronal-specific IL-1 signaling pathway that modu-
lates local inflammatory responses. While AcPb interacts with IL-1 and the IL-1R,
AcPb appears to act via noncanonical IL-1 signaling. Although they have intact
peripheral immune responses, animals lacking AcPb were more vulnerable to local
inflammatory challenge in the CNS and displayed enhanced neuronal degeneration,
suggesting that AcPb may promote neuronal survival during neuroinflammation.
Smith et al. (2009). Immunity 30, 817–831.
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